INCHINN THERAPEUTICS
0799.914.755 · rovalta.com · 26/09/2026
INCHINN THERAPEUTICS
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOINCHINN THERAPEUTICS is a Private limited company incorporated in 2023. Its main activity is: Manufacture of basic pharmaceutical products. Its registered office is in Charleroi.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0799.914.755
- Incorporation
- 24/03/2023
- Legal form
- Private limited company
- Registered office
- Rue Clément Ader 10
6041 Charleroi · WallonieSee on map - Contributed capital
- 10 000,00 €
- Latest accounts
- 31/12/2025
Financials
Source · NBB, 3 filingsTrend over 3 financial years
| 2025 | 2024 | 2023 | |||
|---|---|---|---|---|---|
| Income statement | |||||
| Gross margin | 35,6 k € | +119% | -189,3 k € | -72.8% | -109,6 k € |
| EBITDA | 35,2 k € | +119% | -189,7 k € | -72.5% | -109,9 k € |
| Operating result | 35,2 k € | +119% | -189,7 k € | -72.5% | -109,9 k € |
| Net result | 34,9 k € | +118% | -190,1 k € | -71.1% | -111,1 k € |
| Balance sheet | |||||
| Equity | -256,2 k € | +12.0% | -291,1 k € | -188% | -101,1 k € |
| Total assets | 51,4 k € | +438% | 9,6 k € | -95.2% | 200,5 k € |
| Cash | 39,5 k € | +546% | 6,1 k € | -96.7% | 187,1 k € |
| Debts | 307,6 k € | +2.3% | 300,7 k € | -0.3% | 301,6 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20251 active
Active mandates
Other companies at this address
Rue Clément Ader 10 6041 Charleroi| Company | CBE no. |
|---|---|
2 Bridge WL● Active | 1003.906.745 |
3D Fibroscreen● Active | 1022.772.354 |
AdipoPharma Belgique● Active | 1008.146.338 |
ATRYON BELGIUM● Active | 0751.698.530 |
| 0479.250.670 | |
ConvEyXo● Active | 0725.874.259 |
CONVEYXO GROUP● Active | 1016.957.797 |
ELKEDONIA BELGIUM● Active | 1021.635.177 |
ENDO TOOLS THERAPEUTICS● Active | 0807.570.233 |
Enodia Therapeutics Belgium● Active | 1039.324.811 |
EU BIOTECH CAMPUS● Active | 0776.668.706 |
Exo-Harvest● Active | 0803.425.264 |
Hemastatx● Active | 1019.406.058 |
Immunofusion● Active | 0804.563.629 |
ImmunXperts● Active | 0552.755.587 |
INSTAR BELGIQUE● Active | 1039.395.085 |
KOKUMA● Active | 0799.078.377 |
LYS MEDICAL● Active | 0688.626.061 |
MILEUTIS● Active | 1011.400.984 |
Nexelis Europe● Active | 0744.498.061 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 24/03/2023 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 |
| Length of the financial year | 12 months | 12 months | 10 months |
| Filing date | 31/07/2026 | 30/07/2025 | 31/07/2024 |
| General meeting | 11/06/2026 | 12/06/2025 | 13/06/2024 |
| Currency of the financial year | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 3 filingsValuation
Indicative valuation
As an indication, this company is worth
between 0 € and 100 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active
Active mandates
Ownership and network
Looking for more information about this company?
Try for freePublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202534,9 k €↑
- 2024Annual accounts 2024-190,1 k €↓
- 2023Annual accounts 2023-111,1 k €
- 24/03/2023IncorporationPrivate limited company